Free Republic

Key Points The Food and Drug Administration said it is ending its emergency use authorization of chloroquine and hydroxychloroquine, the anti-malaria drugs backed by President Donald Trump to combat Covid-19. The agency determined the drugs were “unlikely to be effective in treating COVID-19 for the authorized uses in the EUA.” Trump disclosed last month he was taking hydroxychloroquine daily to prevent infection from the coronavirus. ========================================================================== The Food and Drug Administration said Monday it is ending its emergency use authorization of chloroquine and hydroxychloroquine, the anti-malaria drugs backed by President Donald Trump to combat Covid-19. The agency determined the drugs...

The Food and Drug Administration has withdrawn the emergency use authorization for two controversial coronavirus treatment drugs promoted by President Trump because of serious safety issues. The agency said recent clinical trial failures mean chloroquine and hydroxychloroquine may not be effective at treating COVID-19 or preventing it in people who have been exposed, and that their potential benefits do not outweigh the risks. Doctors have warned that the drugs can cause serious heart problems, but the FDA had previously allowed their use for hospitalized patients and during clinical trials. Trump spent weeks promoting the drugs as a potential miracle treatment...